Literature DB >> 11091124

Cardiovascular complications of non-insulin-dependent diabetes: the JCR:LA-cp rat.

T A Clark1, G N Pierce.   

Abstract

Diabetes is a serious medical and financial burden on western societies. It is the seventh leading cause of death in the United States and Canada. The disease is due to a primary defect in glucose tolerance and carbohydrate metabolism resulting from either a deficiency of insulin (Insulin-dependent (type I) diabetes mellitus - IDDM) or a state of insulin resistance (Non-insulin-dependent (type II) diabetes mellitus - NIDDM). NIDDM comprises greater than 80% of total diabetic cases. Associated with the primary metabolic defects are equally deleterious secondary complications affecting the renal, ocular, nervous and cardiovascular systems. The cardiovascular complications account for a major proportion of diabetic mortality. As such, it is of paramount importance to develop or find an animal model expressing complications homologous to the human condition. Many models of NIDDM are available to the diabetic researcher but choosing an accurate one can be difficult. The following compares the advantages and limitations of one such model, the JCR:LA-cp rat to other NIDDM models commonly used today.

Entities:  

Mesh:

Year:  2000        PMID: 11091124     DOI: 10.1016/s1056-8719(00)00081-2

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  11 in total

Review 1.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

Review 2.  Alternative therapies for diabetes and its cardiac complications: role of vanadium.

Authors:  Tod A Clark; Justin F Deniset; Clayton E Heyliger; Grant N Pierce
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

Review 3.  Mouse Models of Heart Failure with Preserved or Reduced Ejection Fraction.

Authors:  Natalie A Noll; Hind Lal; W David Merryman
Journal:  Am J Pathol       Date:  2020-04-25       Impact factor: 4.307

4.  Metallothionein alleviates cardiac contractile dysfunction induced by insulin resistance: role of Akt phosphorylation, PTB1B, PPARgamma and c-Jun.

Authors:  C X Fang; F Dong; B H Ren; P N Epstein; J Ren
Journal:  Diabetologia       Date:  2005-09-20       Impact factor: 10.122

5.  Cardiomyocyte dysfunction in insulin-resistant rats: a female advantage.

Authors:  M L Schwanke; K Dutta; D A Podolin; A J Davidoff
Journal:  Diabetologia       Date:  2006-03-16       Impact factor: 10.122

Review 6.  Rat models for bariatric surgery and surgery for type 2 diabetes mellitus.

Authors:  Sheetal Bharat Mistry; Juan J Omana; Subhash Kini
Journal:  Obes Surg       Date:  2009-03-06       Impact factor: 4.129

7.  Effects on high cholesterol-fed to liver, retina, hippocampus, and Harderian gland in Goto-Kakizaki rat.

Authors:  Kanchana Kengkoom; Aekkarin Klinkhamhom; Aunchalee Sirimontaporn; Ornuma Singha; Taweesak Ketjareon; Yaowaluk Panavechkijkul; Dutmanee Seriwatanachai; Suluck Ukong; Sumate Ampawong
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

8.  Pioglitazone inhibits HIF-1α-dependent angiogenesis in rats by paracrine and direct effects on endothelial cells.

Authors:  Peter Dromparis; Gopinath Sutendra; Roxane Paulin; Spencer Proctor; Evangelos D Michelakis; M Sean McMurtry
Journal:  J Mol Med (Berl)       Date:  2014-01-10       Impact factor: 4.599

9.  n5-STZ Diabetic Model Develops Alterations in Sciatic Nerve and Dorsal Root Ganglia Neurons of Wistar Rats.

Authors:  Francisco Walber Ferreira-da-Silva; Kerly Shamyra da Silva-Alves; Matheus Lemos-Dos-Santos; Keciany Alves de Oliveira; Humberto Cavalcante Joca; Otoni Cardoso do Vale; Andrelina Noronha Coelho-de-Souza; José Henrique Leal-Cardoso
Journal:  ISRN Endocrinol       Date:  2013-02-17

Review 10.  Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes.

Authors:  Bingxuan Wang; P Charukeshi Chandrasekera; John J Pippin
Journal:  Curr Diabetes Rev       Date:  2014-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.